<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31271764</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN><JournalIssue CitedMedium="Internet"><Volume>170</Volume><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Antiviral research</Title><ISOAbbreviation>Antiviral Res</ISOAbbreviation></Journal><ArticleTitle>Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds.</ArticleTitle><Pagination><StartPage>104548</StartPage><MedlinePgn>104548</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2019.104548</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-3542(19)30182-2</ELocationID><Abstract><AbstractText>Oxysterol-binding Protein (OSBP) is a human lipid-transport protein required for the cellular replication of many types of viruses, including several human pathogens. The structurally-diverse small molecule compounds OSW-1, itraconazole (ITZ), T-00127-HEV2 (THEV) and TTP-8307 (TTP) inhibit viral replication through interaction with the OSBP protein. The OSW-1 compound reduces intracellular OSBP, and the reduction of OSBP protein levels persists multiple days after the OSW-1-compound treatment is stopped. The OSW-1-induced reduction of OSBP levels inhibited Enterovirus replication prophylactically in cells. In this report, the OSBP-interacting compounds ITZ, THEV, and TTP are shown not to reduce OSBP levels in cells, unlike the OSW-1-compound, and the OSW-1 compound is determined to be the only compound capable of providing prophylactic antiviral activity in cells. Furthermore, OSW-1 and THEV inhibit the binding of 25-hydroxycholesterol (25-OHC) to OSBP indicating that these compounds bind at the conserved sterol ligand binding site. The ITZ and TTP compounds do not inhibit 25-hydroxycholesterol binding to OSBP, and therefore ITZ and TTP interact with OSBP through other, unidentified binding sites. Co-administration of the THEV compound partially blocks the cellular activity of OSW-1, including the reduction of cellular OSBP protein levels; co-administration of the ITZ and TTP compounds have minimal effect on OSW-1 cellular activity further supporting different modes of interaction with these compounds to OSBP. OSW-1, ITZ, THEV, and TTP treatment alter OSBP cellular localization and levels, but in four distinct ways. Co-administration of OSW-1 and ITZ induced OSBP cellular localization patterns with features similar to the effects of ITZ and OSW-1 treatment alone. Based on these results, OSBP is capable of interacting with multiple structural classes of antiviral small molecule compounds at different binding sites, and the different compounds have distinct effects on OSBP cellular activity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Brett L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severance</LastName><ForeName>Zachary C</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bensen</LastName><ForeName>Ryan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le-McClain</LastName><ForeName>Anh T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malinky</LastName><ForeName>Cori A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mettenbrink</LastName><ForeName>Evan M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nu&#xf1;ez</LastName><ForeName>Juan I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddig</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blewett</LastName><ForeName>Earl L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgett</LastName><ForeName>Anthony W G</ForeName><Initials>AWG</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, United States. Electronic address: anthony.burgett@ou.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM116116</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 CA204706</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Antiviral Res</MedlineTA><NlmUniqueID>8109699</NlmUniqueID><ISSNLinking>0166-3542</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011987">Receptors, Steroid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054899">oxysterol binding protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>767JTD2N31</RegistryNumber><NameOfSubstance UI="C007997">25-hydroxycholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006888" MajorTopicYN="N">Hydroxycholesterols</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011987" MajorTopicYN="N">Receptors, Steroid</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31271764</ArticleId><ArticleId IdType="mid">NIHMS1933050</ArticleId><ArticleId IdType="pmc">PMC10786240</ArticleId><ArticleId IdType="doi">10.1016/j.antiviral.2019.104548</ArticleId><ArticleId IdType="pii">S0166-3542(19)30182-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kentala H; Weber-Boyvat M; Olkkonen VM OSBP-Related Protein Family: Mediators of Lipid Transport and Signaling at Membrane Contact Sites. In International Review of Cell and Molecular Biology; Elsevier Inc., 2016; Vol. 321, pp 299&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">26811291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo A; Ridgway ND Bridging the Molecular and Biological Functions of the Oxysterol-Binding Protein Family. Cell. Mol. Life Sci 2018, 75 (17), 3079&#x2013;3098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11105248</ArticleId><ArticleId IdType="pubmed">29536114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesmin B; Bigay J; Moser von Filseck J; Lacas-Gervais S; Drin G; Antonny B A Four-Step Cycle Driven by PI(4)P Hydrolysis Directs Sterol/PI(4)P Exchange by the ER-Golgi Tether OSBP. Cell 2013, 155 (4), 830&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pubmed">24209621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesmin B; Bigay J; Polidori J; Jamecna D; Lacas-Gervais S; Antonny B Sterol Transfer, PI4P Consumption, and Control of Membrane Lipid Order by Endogenous OSBP. EMBO J. 2017, 36 (21), e201796687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5666618</ArticleId><ArticleId IdType="pubmed">28978670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LH; Gatta AT; Levine TP Lipid Transfer Proteins: The Lipid Commute via Shuttles, Bridges and Tubes. Nat. Rev. Mol. Cell Biol 2019, 20 (2), 85&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">30337668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H; Ma Q; Qi Y; Dong J; Du X; Rae J; Wang J; Wu W-F; Brown AJ; Parton RG; et al. ORP2 Delivers Cholesterol to the Plasma Membrane in Exchange for Phosphatidylinositol 4, 5-Bisphosphate (PI(4,5)P2). Mol. Cell 2019, 73 (3), 458&#x2013;473.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30581148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J; Torta F; Masai K; Lucast L; Czapla H; Tanner LB; Narayanaswamy P; Wenk MR; Nakatsu F; De Camilli P PI4P/Phosphatidylserine Countertransport at ORP5- and ORP8-Mediated ER-Plasma Membrane Contacts. Science (80-. ). 2015, 349 (6246), 428&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4638224</ArticleId><ArticleId IdType="pubmed">26206935</ArticleId></ArticleIdList></Reference><Reference><Citation>Charman M; Colbourne TR; Pietrangelo A; Kreplak L; Ridgway ND Oxysterol-Binding Protein (OSBP)-Related Protein 4 (ORP4) Is Essential for Cell Proliferation and Survival. J. Biol. Chem 2014, 289 (22), 15705&#x2013;15717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140924</ArticleId><ArticleId IdType="pubmed">24742681</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W; Pan G; Wang L; Li S; Ou J; Xu M; Li J; Zhu B; Cao X; Ma H; et al. ORP4L Facilitates Macrophage Survival via G-Protein-Coupled Signaling. Circ. Res 2016, 119 (12), 1296&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">27729467</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan G; Cao X; Liu B; Li C; Li D; Zheng J; Lai C; Olkkonen VM; Zhong W; Yan D OSBP-Related Protein 4L Promotes Phospholipase C&#x3b2;3 Translocation from the Nucleus to the Plasma Membrane in Jurkat T-Cells. J. Biol. Chem 2018, 293 (45), 17430&#x2013;17441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231138</ArticleId><ArticleId IdType="pubmed">30237164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W; Xu M; Li C; Zhu B; Cao X; Li D; Chen H; Hu C; Li R; Luo C; et al. ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLC&#x3b2;3 Catalysis: Targeting It Eradicates Leukemia Stem Cells. Cell Rep. 2019, 26 (8), 2166&#x2013;2177.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30784597</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgett AWG; Poulsen TB; Wangkanont K; Anderson DR; Kikuchi C; Shimada K; Okubo S; Fortner KC; Mimaki Y; Kuroda M; et al. Natural Products Reveal Cancer Cell Dependence on Oxysterol-Binding Proteins. Nat. Chem. Biol 2011, 7 (9), 639&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158287</ArticleId><ArticleId IdType="pubmed">21822274</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BL; Severance ZC; Bensen RC; Le AT; Kothapalli NR; Nu&#xf1;ez JI; Ma H; Wu S; Standke SJ; Yang Z; et al. Transient Compound Treatment Induces a Multigenerational Reduction of Oxysterol-Binding Protein (OSBP) Levels and Prophylactic Antiviral Activity. ACS Chem. Biol 2019, acschembio.8b00984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6379863</ArticleId><ArticleId IdType="pubmed">30576108</ArticleId></ArticleIdList></Reference><Reference><Citation>Strating JRPM; van der Linden L; Albulescu L; Bigay J; Arita M; Delang L; Leyssen P; van der Schaar HM; Lanke KHW; Thibaut HJ; et al. Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein. Cell Rep. 2015, 10 (4), 600&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383725</ArticleId><ArticleId IdType="pubmed">25640182</ArticleId></ArticleIdList></Reference><Reference><Citation>Strating JRPMRPM; van der Linden L; Albulescu L; Bigay J; Arita M; Delang L; Leyssen P; van der Schaar HM; Lanke KHWHW; Thibaut HJJ; et al. Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein. Cell Rep. 2015, 10 (4), 600&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383725</ArticleId><ArticleId IdType="pubmed">25640182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L; Ferla S; Head SA; Bhat S; Pasunooti KK; Shi WQ; Albulescu L; Liu JO; Brancale A; Kuppeveld FJM Van; et al. Structure-Activity Relationship Study of Itraconazole , a Broad-Range Inhibitor of Picornavirus Replication That Targets Oxysterol-Binding Protein (OSBP). Antiviral Res. 2018, 156, 55&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29807040</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulescu L; Strating JRPM; Thibaut HJ; Van Der Linden L; Shair MD; Neyts J; Van Kuppeveld FJM Broad-Range Inhibition of Enterovirus Replication by OSW-1, a Natural Compound Targeting OSBP. Antiviral Res. 2015, 117, 110&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">25752737</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J; Thibaut HJ; Strating JRPM; van Kuppeveld FJM The Life Cycle of Non-Polio Enteroviruses and How to Target It. Nat. Rev. Microbiol 2018, 16 (6), 368&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Amako Y; Sarkeshik A; Hotta H; Yates J; Siddiqui A Role of Oxysterol Binding Protein in Hepatitis C Virus Infection. J. Virol 2009, 83 (18), 9237&#x2013;9246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738263</ArticleId><ArticleId IdType="pubmed">19570870</ArticleId></ArticleIdList></Reference><Reference><Citation>Amako Y; Syed GH; Siddiqui A Protein Kinase D Negatively Regulates Hepatitis C Virus Secretion through Phosphorylation of Oxysterol-Binding Protein and Ceramide Transfer Protein. J. Biol. Chem 2011, 286 (13), 11265&#x2013;11274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3064182</ArticleId><ArticleId IdType="pubmed">21285358</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu CM; Albulescu L; Lyoo H; van Kampen M; De Francesco R; Lohmann V; Harak C; van der Schaar HM; Strating JRPM; Gorbalenya AE; et al. Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase III&#x3b1; and Oxysterol-Binding Protein. mSphere 2016, 1 (3), e00068&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888891</ArticleId><ArticleId IdType="pubmed">27303747</ArticleId></ArticleIdList></Reference><Reference><Citation>Meutiawati F; Bezemer B; Strating JRPM; Overheul GJ; &#x17d;usinaite E; van Kuppeveld FJM; van Cleef KWR; van Rij RP Posaconazole Inhibits Dengue Virus Replication by Targeting Oxysterol-Binding Protein. Antiviral Res. 2018, 157 (June), 68&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">29981375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nchoutmboube J; Ford-Siltz LA; Belov GA Enterovirus Replication: GO with the (Counter)Flow. Trends Microbiol. 2015, 23 (4), 183&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">25748799</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M Phosphatidylinositol-4 Kinase III Beta and Oxysterol-Binding Protein Accumulate Unesterified Cholesterol on Poliovirus-Induced Membrane Structure. Microbiol. Immunol 2014, 58 (4), 239&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">24527995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu CM; Albulescu L; Harak C; Feng Q; van Kampen M; Strating JRPM; Gorbalenya AE; Lohmann V; van der Schaar HM; van Kuppeveld FJM Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus. PLOS Pathog. 2015, 11 (9), e1005185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4583462</ArticleId><ArticleId IdType="pubmed">26406250</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds. J. Virol 2013, 87 (8), 4252&#x2013;4260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624399</ArticleId><ArticleId IdType="pubmed">23365445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchcock CA Resistance of Candida Albicans to Azole Antifungal Agents. Biochem. Soc. Trans 1993, 21 (4), 1039&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">8131894</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong CR; Xu J; Lu J; Bhat S; Sullivan DJ; Liu JO Inhibition of Angiogenesis by the Antifungal Drug Itraconazole. ACS Chem. Biol 2007, 2 (4), 263&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">17432820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacev BA; Grassi P; Dell A; Haslam SM; Liu JO The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells. J. Biol. Chem 2011, 286 (51), 44045&#x2013;44056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243534</ArticleId><ArticleId IdType="pubmed">22025615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J; Tang JY; Gong R; Kim J; Lee JJ; Clemons KV; Chong CR; Chang KS; Fereshteh M; Gardner D; et al. Itraconazole, a Commonly Used Antifungal That Inhibits Hedgehog Pathway Activity and Cancer Growth. Cancer Cell 2010, 17 (4), 388&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039177</ArticleId><ArticleId IdType="pubmed">20385363</ArticleId></ArticleIdList></Reference><Reference><Citation>Head SA; Shi WQ; Yang EJ; Nacev BA; Hong SY; Pasunooti KK; Li R-J; Shim JS; Liu JO Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of MTOR Signaling and Angiogenesis. ACS Chem. Biol 2017, 12 (1), 174&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5791891</ArticleId><ArticleId IdType="pubmed">28103683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q; Yuan S; Zhang C; Wang Y; Wang Y; He G; Zhang S; Altmeyer R; Zou G Discovery of Itraconazole with Broad-Spectrum in Vitro Antienterovirus Activity That Targets Nonstructural Protein 3A. Antimicrob. Agents Chemother 2015, 59 (5), 2654&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394834</ArticleId><ArticleId IdType="pubmed">25691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Im YJ; Raychaudhuri S; Prinz W. a; Hurley JH Structural Mechanism for Sterol Sensing and Transport by OSBP-Related Proteins. Nature 2005, 437 (7055), 154&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1431608</ArticleId><ArticleId IdType="pubmed">16136145</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J; Yang H; Yang H; Eom SH; Im YJ Structure of Osh3 Reveals a Conserved Mode of Phosphoinositide Binding in Oxysterol-Binding Proteins. Structure 2013, 21 (7), 1203&#x2013;1213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23791945</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda K; Anand K; Chiapparino A; Kumar A; Poletto M; Kaksonen M; Gavin A Interactome Map Uncovers Phosphatidylserine Transport by Oxysterol-Binding Proteins. Nature 2013, 501 (7466), 257&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">23934110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J; Yang H; Yang H; Eom SH; Im YJ Structure of Osh3 Reveals a Conserved Mode of Phosphoinositide Binding in Oxysterol-Binding Proteins. Structure 2013, 21 (7), 1203&#x2013;1213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23791945</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung Y-S; Neyts J; Olkkonen VM; et al. Uncovering Oxysterol-Binding Protein (OSBP) as a Target of the Anti-Enteroviral Compound TTP-8307. Antiviral Res. 2017, 140, 37&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088354</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung Y-S; Neyts J; Olkkonen VM; et al. Uncovering Oxysterol-Binding Protein (OSBP) as a Target of the Anti-Enteroviral Compound TTP-8307. Antiviral Res. 2017, 140, 37&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088354</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W; Jin Z Total Synthesis of the Anticancer Natural Product OSW-1. J. Am. Chem. Soc 2002, 124 (23), 6576&#x2013;6583.</Citation><ArticleIdList><ArticleId IdType="pubmed">12047177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimaki Y; Kuroda M; Kameyama A; Sashida Y; Hirano T; Oka K; Maekawa R; Wada T; Sugita K; Beutler JA Cholestane Glycosides with Potent Cytostatic Activities on Various Tumor Cells from Ornithogalum Saundersiae Bulbs. Bioorg. Med. Chem. Lett 1997, 7 (5), 633&#x2013;636.</Citation></Reference><Reference><Citation>Ridgway ND; Dawson PA; Ho YK; Brown MS; Goldstein JL; Ridgway ND; Dawson PA; Ho YK; Brown MS; Goldstein JL Translocation of Oxysterol Binding Protein to Golgi Apparatus Triggered by Ligand Binding. 2008, 116 (2), 307&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289278</ArticleId><ArticleId IdType="pubmed">1730758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridgway ND; Dawson P. a; Ho YK; Brown MS; Goldstein JL Translocation of Oxysterol Binding Protein to Golgi Apparatus Triggered by Ligand Binding. J. Cell Biol 1992, 116 (2), 307&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289278</ArticleId><ArticleId IdType="pubmed">1730758</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>